Role of the ERK5 pathway and CRTC in breast cancer

被引：0
|
作者：
Delepine, E. [1 ]
Hipskind, R. [1 ]
机构：
[1] CNRS, Inst Genet Mol Montpellier, UMR 5535, F-75700 Paris, France
来源：
BULLETIN DU CANCER | 2010年 / 97卷
关键词：
D O I：
10.1016/S0007-4551(15)30945-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway
    Mody, N
    Leitch, J
    Armstrong, C
    Dixon, J
    Cohen, P
    FEBS LETTERS, 2001, 502 (1-2) : 21 - 24
  • [42] Clinical Significance and Regulation of ERK5 Expression and Function in Cancer
    Monti, Matilde
    Celli, Jacopo
    Missale, Francesco
    Cersosimo, Francesca
    Russo, Mariapia
    Belloni, Elisa
    Di Matteo, Anna
    Lonardi, Silvia
    Vermi, William
    Ghigna, Claudia
    Giurisato, Emanuele
    CANCERS, 2022, 14 (02)
  • [43] ERK5 signalling in prostate cancer promotes an invasive phenotype
    A K Ramsay
    S R C McCracken
    M Soofi
    J Fleming
    A X Yu
    I Ahmad
    R Morland
    L Machesky
    C Nixon
    D R Edwards
    R K Nuttall
    M Seywright
    R Marquez
    E Keller
    H Y Leung
    British Journal of Cancer, 2011, 104 : 664 - 672
  • [44] ERK5 signalling in prostate cancer promotes an invasive phenotype
    Ramsay, A. K.
    McCracken, S. R. C.
    Soofi, M.
    Fleming, J.
    Yu, A. X.
    Ahmad, I.
    Morland, R.
    Machesky, L.
    Nixon, C.
    Edwards, D. R.
    Nuttall, R. K.
    Seywright, M.
    Marquez, R.
    Keller, E.
    Leung, H. Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 664 - 672
  • [45] Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
    Lochhead, Pamela A.
    Tucker, Julie A.
    Tatum, Natalie J.
    Wang, Jinhua
    Oxley, David
    Kidger, Andrew M.
    Johnson, Victoria P.
    Cassidy, Megan A.
    Gray, Nathanael S.
    Noble, Martin E. M.
    Cook, Simon J.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [46] Erratum: Neurotrophins use the Erk5 pathway to mediate a retrograde survival response
    Fiona L. Watson
    Heather M. Heerssen
    Anita Bhattacharyya
    Laura Klesse
    Michael Z. Lin
    Rosalind A. Segal
    Nature Neuroscience, 2002, 5 : 1017 - 1017
  • [47] ERK5 and TORC regulate of Cyclin D1 expression in human breast cancer cells
    Delepine, E.
    Hipskind, R. A.
    BULLETIN DU CANCER, 2008, 95 : S29 - S29
  • [48] Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
    Pamela A. Lochhead
    Julie A. Tucker
    Natalie J. Tatum
    Jinhua Wang
    David Oxley
    Andrew M. Kidger
    Victoria P. Johnson
    Megan A. Cassidy
    Nathanael S. Gray
    Martin E. M. Noble
    Simon J. Cook
    Nature Communications, 11
  • [49] SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation
    Erazo, Tatiana
    Espinosa-Gil, Sergio
    Dieguez-Martinez, Nora
    Gomez, Nestor
    Lizcano, Jose M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [50] Role of the interplay between ERK5 and hypoxia in intrahepatic cholangiocarcinoma cells
    Menconi, A.
    Gentilini, A.
    Lori, G.
    Marra, F.
    Rovida, E.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S49 - S49
12345